The primary objective of this study is to evaluate the long-term safety of apremilast in subjects 2 years of age or older with oral ulcers associated with Behçets disease or 5 years of age or older with active juvenile psoriatic arthritis that have completed Study 20190530 or Study 20190529.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
48
Oral tablets or liquid suspension
General Hospital of Thessaloniki Ippokrateio
Thessaloniki, Greece
RECRUITINGMeir Medical Center
Kfar Saba, Israel
RECRUITINGHospital Universitari i Politecnic La Fe
Valencia, Valencia, Spain
Number of Participants with Adverse Events
Adverse events will be classified using the Medical Dictionary for Regulatory Activities (MedDRA) classification system.
Time frame: Up to approximately 4 years
Columbia-Suicide Severity rating Scale (C-SSRS)
A questionnaire used to assess suicide risk.
Time frame: Up to approximately 4 years
Tanner Staging
Tanner Staging of sexual development assessment will be used to assess sexual maturity.
Time frame: Up to approximately 4 years
Change from Baseline in Body Weight
Time frame: Up to approximately 4 years
Change from Baseline in Height
Time frame: Up to approximately 4 years
Change from Baseline in Body Mass Index (BMI)
Time frame: Up to approximately 4 years
Number of Participants with Clinically Significant Changes in Vital Signs
Time frame: Up to approximately 4 years
Number of Participants with Clinically Significant Changes in Laboratory Parameters
Time frame: Up to approximately 4 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Universitario Ramon y Cajal
Madrid, Spain
RECRUITINGHacettepe Universitesi Tip Fakultesi Hastanesi
Ankara, Turkey (Türkiye)
RECRUITINGIstanbul Universitesi Cerrahpasa Tip Fakultesi
Istanbul, Turkey (Türkiye)
RECRUITINGUmraniye Egitim ve Arastirma Hastanesi
Istanbul, Turkey (Türkiye)
RECRUITING